Secondary’s Announced 2.11.2015

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. To subscribe to his secondary ratings, click here.

Company: Transition Therapeutics Inc.
Symbol: TTHI
Price: Last trade $7.08
Trade Date: 2/12
Shares: 2.8 million
Underwriter(s) Cowen & Co.
Co Manager(s) Canaccord Genuity, H.C. Wainwright, LifeSci Capital
Rating=Subscription Needed

Company: Harvard apparatus Regenerative Technology, Inc.
Symbol: HART
Price: Last trade $1.89
Trade Date: 2/12
Shares: TBD
Underwriter(s) National Securities
Co Manager(s) Summer Street Research Partners
Rating=Subscription Needed